Daily opioid analgesic use reduces blood insulin levels

Christina Mueller, MS; Larry F. Chu, MD; Joanne C. Lin, PhD; Fernando Ovalle, MD; Jarred W. Younger, PhD

doi:10.5055/jom.2018.0446

Authors

Christina Mueller, MS
Larry F. Chu, MD
Joanne C. Lin, PhD
Fernando Ovalle, MD
Jarred W. Younger, PhD

DOI:

https://doi.org/10.5055/jom.2018.0446

Keywords:

blood insulin, opioid analgesic, daily opioid

Abstract

-

Author Biographies

Christina Mueller, MS

Graduate Student, Department of Psychology, The University of Alabama at Birmingham, Birmingham, Alabama

Larry F. Chu, MD

Professor, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California

Joanne C. Lin, PhD

Postdoctoral Research Fellow, The University of Alabama at Birmingham, Birmingham, Alabama

Fernando Ovalle, MD

Associate Professor, Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama

Jarred W. Younger, PhD

Associate Professor, Department of Psychology, The University of Alabama at Birmingham, Birmingham, Alabama

References

Daniell HW: DHEAS deficiency during consumption of sustained-action prescribed opioids: Evidence for opioid-induced inhibition of adrenal androgen production. J Pain. 2006; 7(12): 901-907.

Gudin JA, Laitman A, Nalamachu S: Opioid related endocrinopathy. Pain Med. 2015; 16(suppl 1): S9-S15.

Faskowitz AJ, Kramskiy VN, Pasternak GW: Methadone-induced hypoglycemia. Cell Mol Neurobiol. 2013; 33(4): 537-542.

Golightly LK, Simendinger BA, Barber GR, et al.: Hypoglycemic effects of tramadol analgesia in hospitalized patients: A case-control study. J Diabetes Metab Disords. 2017; 16: 30.

Flory JH, Wiesenthal AC, Thaler HT, et al.: Methadone use and the risk of hypoglycemia for inpatients with cancer pain. J Pain Symptom Manage. 2016; 51(1): 79-87.

Maingi S, Moryl N, Andrew F: (244) Symptomatic hypoglycemia due to escalating doses of intravenous methadone. J Pain. 2008; 9(4): 37.

Feldberg W, Gupta KP: Morphine hyperglycaemia. J Physiol. 1974; 238(3): 487-502.

Garcia-Barrado MJ, Iglesias-Osma MC, Rodriguez R, et al.: Role of mu-opioid receptors in insulin release in the presence of inhibitory and excitatory secretagogues. Eur J Pharmacol. 2002; 448(1): 95-104.

Ishizuka JIN, Toyota T, Ono T, et al.: Inhibitory effects of rimorphin and dynorphin on insulin secretion from the isolated, perfused rat pancreas. Tohoku J Exp Med. 1986; 150(1): 17-24.

Wen T, Peng B, Pintar JE: The MOR-1 opioid receptor regulates glucose homeostasis by modulating insulin secretion. Mol Endocrinol. 2009; 23(5): 671-678.

Fatouros IG, Goldfarb AH, Jamurtas AZ, et al.: Betaendorphin infusion alters pancreatic hormone and glucose Levels during exercise in rats. Eur J Appl Physiol Occup Physiol. 1997; 76(3): 203-208.

Giugliano D, Cozzolino D, Ceriello A, et al.: Beta-endorphin and islet hormone release in humans: Evidence for interference with cAMP. Am J Physiol. 1989; 257(3)(Pt 1): E361-E366.

Zheng SX, Bosch MA, Ronnekleiv OK: mu-opioid receptor mRNA expression in identified hypothalamic neurons. J Comp Neurol. 2005; 487(3): 332-344.

Tuduri E, Beiroa D, Stegbauer J, et al.: Acute stimulation of brain mu opioid receptors inhibits glucose-stimulated insulin secretion via sympathetic innervation. Neuropharmacology. 2016; 110(Pt A): 322-332.

Hutchinson MR, Bland ST, Johnson KW, et al.: Opioid-induced glial activation: Mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci World J. 2007; 7: 98-111.

Lin JC, Chu LF, Stringer EA, et al.: One month of oral morphine decreases gray matter volume in the right amygdala of individuals with low back pain: Confirmation of previously reported magnetic resonance imaging results. Pain Med. 2016; 17(8): 1497-1504.

Vuong C, Van Uum SH, O'Dell LE, et al.: The effects of opioids and opioid analogs on animal and human endocrine systems. Endocrine Rev. 2010; 31(1): 98-132.